Effect of armodafinil on cortical activity and working memory in patients with residual excessive sleepiness associated with CPAP-treated OSA: A Multicenter fMRI Study

Douglas N. Greve, Stephen P. Duntley, Linda Larson-Prior, Andrew D. Krystal, Michele T. Diaz, Sean P.A. Drummond, Stephen G. Thein, Clete A. Kushida, Ronghua Yang, Robert J. Thomas

Research output: Contribution to journalArticle

5 Scopus citations

Abstract

Study Objective: To assess the effect of armodafinil on task-related prefrontal cortex activation using functional magnetic resonance imaging (fMRI) in patients with obstructive sleep apnea (OSA) and excessive sleepiness despite continuous positive airway pressure (CPAP) therapy. Methods: This 2-week, multicenter, prospective, randomized, double-blind, placebo-controlled, parallel-group study was conducted at five neuroimaging sites and four collaborating clinical study centers in the United States. Patients were 40 right-handed or ambidextrous men and women aged between 18 and 60 years, with OSA and persistent sleepiness, as determined by multiple sleep latency and Epworth Sleepiness Scale scores, despite effective, stable use of CPAP. Treatment was randomized (1:1) to once-daily armodafinil 200 mg or placebo. The primary efficacy outcome was a change from baseline at week 2 in the volume of activation meeting the predefined threshold in the dorsolateral prefrontal cortex during a 2-back working memory task. The key secondary measure was the change in task response latency. Results: No significant differences were observed between treatment groups in the primary or key secondary outcomes. Armodafinil was generally well tolerated. The most common adverse events (occurring in more than one patient [5%]) were headache (19%), nasopharyngitis (14%), and diarrhea (10%). Conclusions: Armodafinil did not improve fMRI-measured functional brain activation in CPAP-treated patients with OSA and excessive sleepiness.

Original languageEnglish (US)
Pages (from-to)143-153
Number of pages11
JournalJournal of Clinical Sleep Medicine
Volume10
Issue number2
DOIs
StatePublished - 2014

All Science Journal Classification (ASJC) codes

  • Pulmonary and Respiratory Medicine
  • Neurology
  • Clinical Neurology

Fingerprint Dive into the research topics of 'Effect of armodafinil on cortical activity and working memory in patients with residual excessive sleepiness associated with CPAP-treated OSA: A Multicenter fMRI Study'. Together they form a unique fingerprint.

  • Cite this

    Greve, D. N., Duntley, S. P., Larson-Prior, L., Krystal, A. D., Diaz, M. T., Drummond, S. P. A., Thein, S. G., Kushida, C. A., Yang, R., & Thomas, R. J. (2014). Effect of armodafinil on cortical activity and working memory in patients with residual excessive sleepiness associated with CPAP-treated OSA: A Multicenter fMRI Study. Journal of Clinical Sleep Medicine, 10(2), 143-153. https://doi.org/10.5664/jcsm.3440